Publication | Closed Access

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

HepatologyHepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyPlacebo-controlled TrialChronic Viral InfectionAntiviral DrugMedicinePhase 3Treatment-naive Patients